SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-031193
Filing Date
2011-05-19
Accepted
2011-05-19 17:13:34
Documents
1
Period of Report
2011-05-17

Document Format Files

Seq Description Document Type Size
1 v223513_ex.html 4  
1 v223513_ex.xml 4 4745
  Complete submission text file 0001144204-11-031193.txt   6229
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 AVENUE OF THE AMERICAS NEW YORK NY 10019
Business Address
TAUB MALCOLM S (Reporting) CIK: 0001305117 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54365 | Film No.: 11858740